A clinical update on tuberous sclerosis complex‐associated neuropsychiatric disorders (TAND)

Authors:

Abstract
Tuberous sclerosis complex (TSC) is associated with a wide range of behavioral, psychiatric, intellectual, academic, neuropsychological, and psychosocial difficulties, which are often underdiagnosed and undertreated. Here, we present a clinical update on TSC‐associated neuropsychiatric disorders, abbreviated as “TAND,” to guide screening, diagnosis, and treatment in practice. The review is aimed at clinical geneticists, genetic counselors, pediatricians, and all generalists involved in the assessment and treatment of children, adolescents and adults with TSC, and related disorders. The review starts with a summary of the construct and levels of TAND, before presenting up‐to‐date information about each level of investigation. The review concludes with a synopsis of current and future TAND research.
Funding Information
  • National Institute of Neurological Disorders and Stroke (NS082320, U54NS092090, U01 NS092595)
  • Texas Higher Education Coordinating Board
  • Health Resources and Services Administration
  • National Institutes of Health (NS082320, U54NS092090, U01 NS092595)
  • Novartis
  • National Research Foundation

This publication has 84 references indexed in Scilit: